Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus | Zendy

Qi-Zhen Zhuang | Zendy; Zhenzhen Li | Zendy; Chao Yan | Zendy; Fei Li | Zendy; Yi-Yuan Ge | Zendy; Yan-Hua Sha | Zendy; Yi Wang | Zendy; Xianzhang Huang | Zendy; Pei-Feng Ke | Zendy; Yujuan Xiong | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus

Author(s) -

Qi-Zhen Zhuang,

Zhenzhen Li,

Chao Yan,

Fei Li,

Yi-Yuan Ge,

Yan-Hua Sha,

Yi Wang,

Xianzhang Huang,

Pei-Feng Ke,

Yujuan Xiong

Publication year - 2021

Publication title -

clinical laboratory

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.361

H-Index - 46

ISSN - 1433-6510

DOI - 10.7754/clin.lab.2020.201025

Subject(s) - covid-19 , nucleic acid , virology , sars virus , computational biology , nucleic acid amplification tests , biology , medicine , genetics , pathology , outbreak , disease , chlamydia trachomatis , infectious disease (medical specialty)

COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research